+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Xaracoll"

From
United States XARACOLL Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States XARACOLL Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Xaracoll is a type of analgesic, or pain reliever, that is used to treat moderate to severe pain. It is a long-acting, injectable form of bupivacaine, a local anesthetic. Xaracoll is administered via a subcutaneous injection, and its effects can last up to 72 hours. It is used to treat post-operative pain, as well as chronic pain conditions such as osteoarthritis and low back pain. Xaracoll is also used to treat pain associated with cancer and other medical conditions. Xaracoll is a relatively new analgesic, and the market is still in its early stages. It is expected to grow in the coming years, as more people become aware of its potential benefits. The market is highly competitive, with several companies offering Xaracoll products. Some of the major players in the Xaracoll market include Pacira Pharmaceuticals, Inc., Endo Pharmaceuticals, Inc., and Mylan N.V. Show Less Read more